High real-world effectiveness of elbasvir/grazoprevir in PWID on opioid substitution therapy with HCV genotype 1 infection: Results from the German hepatitis C registry (DHC-R)

被引：0
|
作者：
Christensen, Stefan [1 ]
Stoehr, Albrecht [2 ]
Cornberg, Markus [3 ]
Klinker, Hartwig [4 ]
Heyne, Renate [5 ]
John, Christine
Simon, Karl-Georg [6 ]
Bilzer, Manfred [7 ]
Guenther, Veronika [8 ]
Witte, Vanessa [8 ]
Reimer, Jens [9 ,10 ]
机构：
[1] CIM Muenster, Munster, Germany
[2] Study Ctr St Georg, Ifi Inst Interdisciplinary Med, Hamburg, Germany
[3] Hannover Med Sch, Hannover, Germany
[4] Univ Hosp Wuerzburg, Wurzburg, Germany
[5] Leberzentrum Checkpoint, Berlin, Germany
[6] Schwarz GbR, MVZ Dres Eisenbach, Leverkusen, Germany
[7] Bilzer Consulting, Munich, Germany
[8] MSD Sharp & Dohme GmbH, Haar, Germany
[9] Univ Hosp Hamburg, Hamburg, Germany
[10] Hlth North Hosp Grp Bremen, Bremen, Germany
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30400-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-125
引用
收藏
页码：E214 / E214
页数：1
相关论文
共 50 条
  • [41] Chronic Hepatitis C Genotype 1 German Hepatitis C-Registry: Elbasvir/Grazoprevir also achieved high Cure Rates in Cirrhosis
    不详
    VISCERAL MEDICINE, 2019, 35 (03) : 199 - 199
  • [42] Weight gain after interferon-free clearance of chronic hepatitis C: Results from the German hepatitis C registry (DHC-R)
    Schlevogt, Bernhard
    Boeker, Klaus
    Mauss, Stefan
    Klinker, Hartwig
    Heyne, Renate
    Link, Ralph
    Simon, Karl-Georg
    Sarrazin, Christoph
    Manns, Michael P.
    Wedemeyer, Heiner
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E239 - E239
  • [43] Scaling up HCV-DAA treatment in patients on opioid substitution therapy (OST) - does alcohol and cannabis diminish cure rates? Data from the German Hepatitis C-Registry (DHC-R)
    Christensen, S.
    Buggisch, P.
    Mauss, S.
    Boeker, K.
    Mueller, T.
    Klinker, H.
    Zimmermann, T.
    Serfert, Y.
    Weber, B.
    Reimer, J.
    Wedemeyer, H.
    C-Register, D. H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S21 - S22
  • [44] CLINICAL IMPORTANT CHANGES IN HEALTH -RELATED QUALITY OF LIFE AFTER TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION WITH DIRECT ACTING ANTIVIRALS IN A LARGE REAL-WORLD SETTING- RESULTS FROM THE GERMAN HEPATITIS C-REGISTRY (DHC-R)
    Ohlendorf, Valerie
    Schaefer, Arne
    Christensen, Stefan
    Heyne, Renate
    Naumann, Uwe
    Link, Ralph
    Herold, Christoph
    Schiffelholz, VVillibold
    Guenther, Rainer
    Comberg, Markus
    Serfert, Yvonne
    Maasoumy, Benjamin
    Wedemeyer, Heiner
    Kraus, Michael
    HEPATOLOGY, 2020, 72 : 581A - 582A
  • [45] Retreatment with Voxilaprevir/Velpatasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus Infection and Prior Daa Failure - Results from the German Hepatitis C-Registry (DHC-R)
    Vermehren, Johannes
    Stoehr, Albrecht
    Zur Wiesch, Julian Schulze
    Klinker, Hartwig
    Cornberg, Markus
    Jung, Maria-Christina
    Simon, Karl-Georg
    Serfert, Yvonne
    Manns, Michael P.
    Wedemeyer, Heiner
    Sarrazin, Christoph
    HEPATOLOGY, 2018, 68 : 401A - 402A
  • [46] Drug-Drug Interaction Potential of Glecaprevir/Pibrentasvir Based on Real-World Use of Co-Medications in Patients with Chronic Hepatitis C Virus Infection: Data from the German Hepatitis C Registry (DHC-R)
    Vermehren, Johannes
    Boeker, Klaus H. W.
    Bondin, Mark I.
    Mauss, Stefan
    Pathil, Anita
    Klinker, Hartwig
    Lutz, Thomas
    Marra, Fiona
    Hettinger, Jan
    Kleine, Henning
    Buggisch, Peter
    HEPATOLOGY, 2018, 68 : 409A - 410A
  • [47] LEDIPASVIR/SOFOSBUVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE HCV GENOTYPE 1 INFECTED PATIENTS UNDER REAL LIFE CONDITIONS: DATA FROM THE GERMAN HEPATITIS C-REGISTRY (DHC-R)
    Buggisch, P.
    Boeker, K. H. W.
    Guenther, R.
    Teuber, G.
    Klinker, H.
    Pathil, A.
    Christensen, S.
    Peiffer-Vornkahl, H.
    Simon, K. -G.
    Niederau, C.
    Wedemeyer, H.
    Zeuzem, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S810 - S810
  • [48] Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R)
    Ohlendorf, Valerie
    Schaefer, Arne
    Christensen, Stefan
    Heyne, Renate
    Naumann, Uwe
    Link, Ralph
    Herold, Christoph
    Schiffelholz, Willibold
    Guenther, Rainer
    Cornberg, Markus
    Serfert, Yvonne
    Maasoumy, Benjamin
    Wedemeyer, Heiner
    Kraus, Michael R.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (08) : 1206 - 1218
  • [49] Elbasvir/Grazoprevir effectiveness in patients with Chronic Hepatitis C and Chronic Kidney Disease: real-world experience from the TRIO Network
    Younossi, Z.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Flamm, S.
    Kowdley, K.
    Milligan, S.
    Nwankwo, C.
    Tsai, N.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S748 - S749
  • [50] Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4
    Zarebska-Michaluk, Dorota
    Jaroszewicz, Jerzy
    Buczynska, Iwona
    Simon, Krzysztof
    Lorenc, Beata
    Tudrujek-Zdunek, Magdalena
    Tomasiewicz, Krzysztof
    Sitko, Marek
    Garlicki, Aleksander
    Janczewska, Ewa
    Dybowska, Dorota
    Halota, Waldemar
    Pawlowska, Malgorzata
    Pabjan, Pawel
    Mazur, Wlodzimierz
    Czauz-Andrzejuk, Agnieszka
    Berak, Hanna
    Horban, Andrzej
    Socha, Lukasz
    Klapaczynski, Jakub
    Piekarska, Anna
    Blaszkowska, Maria
    Belica-Wdowik, Teresa
    Dobracka, Beata
    Tronina, Olga
    Deron, Zbigniew
    Bialkowska-Warzecha, Jolanta
    Laurans, Lukasz
    Flisiak, Robert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1238 - 1246
12345